Lista de obras - Santiago Montes-Moreno - Dominio Público Uruguay

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

artículo científico publicado en 2011

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group

artículo científico publicado en 2018

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages

artículo científico publicado en 2010

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2017

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

artículo científico publicado en 2015

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

artículo científico publicado en 2010

Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with particular immunophenotypic features

artículo científico publicado en 2013

Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression

artículo científico publicado en 2016

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

artículo científico

BCL7A protein expression in normal and malignant lymphoid tissues.

artículo científico publicado en 2012

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

artículo científico publicado en 2018

CD 30-positive transformed follicular lymphoma: two case reports and literature review.

artículo científico

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

artículo científico publicado en 2015

CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.

artículo científico publicado en 2015

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2013

Castleman Disease and Rosai-Dorfman Disease.

artículo científico publicado en 2017

Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: A previously undescribed association of findings

artículo científico publicado en 2005

Childhood florid follicular hyperplasia with immunoglobulin light-chain restriction in the gastrointestinal tract

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

artículo científico publicado en 2014

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

artículo científico publicado en 2016

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

artículo científico publicado en 2011

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

artículo científico publicado en 2014

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era

artículo científico publicado en 2018

Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

scientific article published on 07 April 2018

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway

artículo científico publicado en 2011

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

artículo científico publicado en 2012

Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.

artículo científico publicado en 2012

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers

artículo científico publicado en 2018

Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS

artículo científico publicado en 2020

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

artículo científico publicado en 2011

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

artículo científico publicado en 2012

EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults

artículo científico publicado en 2010

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation

artículo científico publicado en 2012

Early phase of Epstein-Barr virus (EBV)-positive diffuse large B cell lymphoma of the elderly mimicking EBV-positive reactive follicular hyperplasia

artículo científico publicado en 2011

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

artículo científico publicado en 2011

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options

artículo científico publicado en 2016

Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases

artículo científico publicado en 2011

Erdheim-Chester disease with isolated skeletal involvement in patient with odontalgia.

artículo científico publicado en 2017

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

artículo científico

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

artículo científico publicado en 2015

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

artículo científico publicado en 2013

Expression pattern of XBP1(S) in human B-cell lymphomas

artículo científico publicado en 2009

Follicular T-cell lymphoma: description of a case with characteristic findings suggesting it is a different condition from AITL

artículo científico publicado en 2009

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

artículo científico publicado en 2007

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma

scientific article published on 09 April 2020

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

artículo científico publicado en 2017

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

artículo científico publicado en 2013

Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice

artículo científico publicado en 2012

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

artículo científico publicado en 2015

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment ⬇️

artículo científico publicado el 24 de octubre de 2010

Identification of MNDA as a new marker for nodal marginal zone lymphoma.

artículo científico publicado en 2009

Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues

article published in 2011

In situ neoplasia in lymph node pathology.

artículo científico publicado en 2017

Incidental and Isolated Follicular Lymphoma In Situ and Mantle Cell Lymphoma In Situ Lack Clinical Significance

artículo científico publicado en 2016

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

article

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

artículo científico publicado en 2011

Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.

artículo científico publicado en 2014

Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases.

artículo científico publicado en 2010

Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma

artículo científico publicado en 2012

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

artículo científico publicado en 2011

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

artículo científico publicado en 2016

Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.

artículo científico publicado en 2014

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

artículo científico publicado en 2009

Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis

artículo científico publicado en 2019

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2013

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

artículo científico publicado en 2013

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

artículo científico publicado en 2015

MYD88L265P mutated IgA lymphoplasmacytic lymphoma

artículo científico publicado en 2019

MicroRNA signatures in B-cell lymphomas.

artículo científico publicado en 2012

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

artículo científico publicado en 2012

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

artículo científico publicado en 2012

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.

artículo científico publicado en 2014

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

artículo científico publicado en 2014

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

artículo científico publicado en 2013

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.

artículo científico publicado en 2011

Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins

PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma

artículo científico publicado en 2008

Pathology reporting of bone marrow biopsy in myelofibrosis; application of the Delphi consensus process to the development of a standardised diagnostic report

article

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Peripheral T-cell lymphoma with follicular T-cell markers

artículo científico publicado en 2008

Persistent polyclonal B-cell lymphocytosis with splenomegaly: histologic description of 2 cases

artículo científico publicado en 2013

Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1.

artículo científico publicado en 2016

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

artículo científico publicado en 2014

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers

artículo científico publicado en 2009

Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features

Primary luetic lymphadenopathy simulating sarcoma-like inflammatory pseudotumour of the lymph node

Procesos linfoproliferativos múltiples en un paciente

artículo científico publicado en 2016

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

artículo científico publicado en 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Proliferation centers in chronic lymphocytic leukemia: the niche where NF-κB activation takes place

artículo científico publicado en 2010

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

artículo científico publicado en 2016

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

artículo científico publicado en 2018

Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.

artículo científico publicado en 2014

SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

artículo científico publicado en 2012

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

artículo científico publicado en 2013

Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma

article

Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features

artículo científico publicado en 2010

Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases

artículo científico publicado en 2009

Spontaneously Ruptured Spleen Samples in Patients With Infectious Mononucleosis: Analysis of Histology and Lymphoid Subpopulations

artículo científico publicado en 2018

Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.

artículo científico publicado en 2016

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

artículo científico publicado en 2008

TCR-γ expression in primary cutaneous T-cell lymphomas.

artículo científico publicado en 2013

Targeting CD30 expression in diverse Large B-cell lymphoma entities

The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

artículo científico publicado en 2014

The broad and challenging landscape of extranodal lymphoproliferations

artículo científico publicado en 2019

The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome

artículo científico publicado en 2019

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

artículo científico publicado en 2010

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

artículo científico

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

artículo científico publicado en 2012

Ultrastructural Studies in a Series of 18 Cases of Chromophobe Renal Cell Carcinoma

article published in 2005

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma

artículo científico publicado en 2019

Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas

scientific article published on 26 November 2019

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy

artículo científico publicado en 2011

p-MAPK1 expression associated with poor prognosis in angioimmunoblastic T-cell lymphoma patients

artículo científico publicado en 2016

Lista de obras de Santiago Montes-Moreno

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with particular immunophenotypic features

Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies

BCL7A protein expression in normal and malignant lymphoid tissues.

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

CD 30-positive transformed follicular lymphoma: two case reports and literature review.

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Castleman Disease and Rosai-Dorfman Disease.

Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: A previously undescribed association of findings

Childhood florid follicular hyperplasia with immunoglobulin light-chain restriction in the gastrointestinal tract

Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era

Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers

Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation

Early phase of Epstein-Barr virus (EBV)-positive diffuse large B cell lymphoma of the elderly mimicking EBV-positive reactive follicular hyperplasia

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options

Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases

Erdheim-Chester disease with isolated skeletal involvement in patient with odontalgia.

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

Expression pattern of XBP1(S) in human B-cell lymphomas

Follicular T-cell lymphoma: description of a case with characteristic findings suggesting it is a different condition from AITL

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

Hodgkin's Lymphomas: A Tumor Recognized by Its Microenvironment ⬇️

Identification of MNDA as a new marker for nodal marginal zone lymphoma.

Immunohistochemical analysis of HLDA9 Workshop antibodies against cell-surface molecules in reactive and neoplastic lymphoid tissues

In situ neoplasia in lymph node pathology.

Incidental and Isolated Follicular Lymphoma In Situ and Mantle Cell Lymphoma In Situ Lack Clinical Significance

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.

Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases.

Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma

Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.

MYD88L265P mutated IgA lymphoplasmacytic lymphoma

MicroRNA signatures in B-cell lymphomas.

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas.

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets.